Skip to main content
. 2019 May 30;10(4):488–498. doi: 10.1016/j.jshs.2019.05.009

Table 3.

Lung function measures for participants within the intervention and control groups with asthma and without asthma.

Asthma
Non-asthma
n Baseline Mid-intervention Post-intervention Follow-up n Baseline Mid-intervention Post-intervention Follow-up
Intervention
FEV1 (% predicted) 29 93.5 ± 15.5 94.7 ± 14.1 92.2 ± 14.8 88.1 ± 15.8 90 93.9 ± 16.5* 95.7 ± 13.8 97.1 ± 13.4 91.3 ± 15.4
FVC (% predicted) 29 102.4 ± 13.2 102.5 ± 13 100.4 ± 14.7 94.9 ± 17.7 90 99.5 ± 13.8 100.8 ± 13.1 101.5 ± 18.3 94.5 ± 16.4
FEV1/FVC 29 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 90 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1
FEF25–75 (% predicted) 29 78.2 ± 28.0 81.7 ± 22.5 77.7 ± 31.3 77.1 ± 24.1 90 83.1 ± 23.8* 86.9 ± 23.4 89.2 ± 26.7 85.2 ± 25.4
PEF (% predicted) 29 90.0 ± 18.5 89.5 ± 20.9 91.4 ± 19.1 85.7 ± 22.8 90 87.8 ± 19.8 90.0 ± 19.4 93.9 ± 17.9 88.5 ± 20.7
FeNO (ppb) 29 40.3 ± 31.2 38.5 ± 31.3 38.6 ± 27.4 0
Control
FEV1 (% predicted) 68 90.1 ± 14.7 87.9 ± 19.4 92.8 ± 18.4 91.7 ± 13.5 155 96.1 ± 17.2* 90.8 ± 19.5 96.1 ± 14.3 97.1 ± 16.6
FVC (% predicted) 68 97.3 ± 14.6 96.0 ± 20.5 98.5 ± 20.1 97.0 ± 14.0 155 99.7 ± 15.0 92.9 ± 19.0 97.8 ± 13.7 98.1 ± 13.4
FEV1/FVC 68 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 155 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1
FEF25–75 (% predicted) 68 75.6 ± 24.8 74.6 ± 29.0 79.0 ± 23.9 80.4 ± 21.3 155 88.2 ± 26.2* 85.6 ± 26.2 91.9 ± 23.3 92.5 ± 24.5
PEF (% predicted) 68 93.0 ± 21.1 89.7 ± 25.1 91.0 ± 15.2 91.5 ± 17.9 155 91.1 ± 21.4 87.6 ± 24.1 92.8 ± 17.0 92.8 ± 18.9
FeNO (ppb) 70 43.6 ± 38.8 41.9 ± 39.7 41.4 ± 38.1 0

Note: Data are presented as n or mean ± SD as indicated.

Abbreviations: % predicted = expressed as a percentage of the age–sex–stature predicted value; FeNO = fractional exhaled nitric oxide; FEF25–75 = forced expiratory flow between 25% and 75% of vital capacity; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; PEF = peak expiratory flow; ppb = parts per billion.

p < 0.05, significantly different from Asthma at baseline.